Evidence map›Paper›PMID 41074012›Full record

ArticleHarm reduction journal2025

A feminist analysis of women's performance and image-enhancing drug use: epistemic injustice and resources for rethinking enhancement harms.

Renae Fomiatti, Kay Stanton

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Renae FomiattiAustralian Research Centre of Sex, Health and Society, La Trobe University, Melbourne, Australia. r.fomiatti@latrobe.edu.au.
Kay StantonYour Community Health, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article examines women's accounts of using performance and image-enhancing drugs in the context of fitness and strength-training. It explicitly engages in a mode of feminist knowledge production to rethink the harms women experience as a feature of epistemic injustice and gendered discrimination rather than personal inability, consumption or drug effects alone. Drawing on theorisations of epistemic agency and injustice (Fricker, 2007; Haraway, 1988) alongside 10 qualitative interviews with women who use substances for strength-training in Melbourne, Australia, we attend to the social and political features of drug consumption, and women's accounts of bodily transformation and harms. Women overwhelmingly described consumption in relation to enhanced autonomy, with substances functioning as technologies of self-realisation within domestic and work responsibilities and gendered relations of power, as well as a route to enhanced social lives. In contrast to epistemically authoritative discourses in which women have little knowledge of the substances they are consuming and knowingly downplay the potential for side effects, our participants possessed detailed forms of knowledge and skill, and actively sought to monitor and prevent side effects, including virilisation, in the absence of reliable, gender-sensitive health information and healthcare. The most pressing forms of harm women experienced were gender-related stigma and discrimination, and insufficient gender-specific healthcare, related, in part, to epistemic exclusion and injustice in research and healthcare. By prioritising women's accounts and attending to embodiment and social practices, our analysis complicates normative knowledge claims about women's risk, coercion and pathologies, and suggests new epistemic resources for understanding women's consumption as socially and materially meaningful, and enhancement harm reduction more broadly.

Indexed as

FeminismPerformance-Enhancing SubstancesSubstance-Related DisordersAdultAustraliaFemaleHarm ReductionHealth Knowledge, Attitudes, PracticeHumansMiddle AgedQualitative ResearchSocial JusticeYoung AdultPerformance-Enhancing Substances

Identifiers

PMID41074012
PMCPMC12512920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.